Lessee, Operating Lease, Liability, to be Paid, Year Two of Propanc Biopharma, Inc. from 30 Jun 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Propanc Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 30 Jun 2019 to 31 Dec 2025.
  • Propanc Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2025 was $24,256.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $24,256 31 Dec 2025 10-Q 17 Feb 2026 2026 Q2
Q3 2025 $24,085 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q2 2025 $25,045 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q2 2023 $19,992 -$4,902 -20% 30 Jun 2023 10-K 28 Sep 2023 2023 FY
Q1 2023 $20,091 31 Mar 2023 10-Q 15 May 2023 2023 Q3
Q4 2022 $20,415 31 Dec 2022 10-Q 10 Feb 2023 2023 Q2
Q3 2022 $23,155 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q2 2022 $24,894 30 Jun 2022 10-K 28 Sep 2022 2022 FY
Q1 2020 $22,822 31 Mar 2020 10-Q 15 May 2020 2020 Q3
Q4 2019 $23,119 31 Dec 2019 10-Q 14 Feb 2020 2020 Q2
Q3 2019 $22,778 30 Sep 2019 10-Q 14 Nov 2019 2020 Q1
Q2 2019 $28,325 30 Jun 2019 10-K 15 Oct 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.